The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
The NF-κB pathway
Open accessAbstract
The nuclear factor (NF)-κB transcription factor regulates expression of numerous components of the immune system (Li and Verma, 2002). These include proinflammatory cytokines, chemokines, adhesion molecules and inducible enzymes such as cycloxygenase-2 and inducible nitric oxide synthase, which regulate the innate immune response, as well as proteins that regulate the specific immune response, such as major histocompatibility complex and co-stimulatory molecules crucial to the induction phase of specific immunity, and cytokines like interleukin (IL)-2, IL-12 and interferon-γ that control lymphocyte proliferation and differentiation. Dysregulation of this transcription factor can thus lead to inflammatory and autoimmune diseases (Yamamoto and Gaynor, 2001). Since NF-κB also regulates the expression of a variety of proteins that inhibit apoptosis and promote cell survival/proliferation, it is also implicated in carcinogenesis (Karin et al., 2002).FIG1NF-κB describes various dimeric complexes of members of the Rel protein family, which comprises Rel (c-Rel), Rel A (p65), RelB, NF-κB1 (p50 and its precursor p105) and NF-κB2 (p52 and its precursor p100) (Ghosh et al., 1998). Each possesses an ∼300-residue N-terminal Rel-homology-domain, responsible for dimerisation, nuclear translocation and DNA binding. p65, RelB and c-Rel, also contain a C-terminal transactivation domain. Of the various dimeric combinations, p50-p65 is most common. Binding of most NF-κB complexes to motifs in target promoters assists transcription, but homodimeric complexes of p50 or p52 can repress it.In resting cells, NF-κB proteins are predominantly cytoplasmic, associating with members of the inhibitory IκB family such as IκB-α, IκB-β and IκB-ϵ (Ghosh et al., 1998). These interact with NF-κB through multiple ankyrin repeats and also inhibit its DNA-binding activity. IκB proteins were originally thought to sequester NF-κB in the cytoplasm by masking its nuclear localisation sequences (NLSs). However, IκB-α (and probably IκB-ϵ) can only mask one NLS in the dimer; so NF-κB-IκBα complexes undergo constitutive nuclear translocation (Malek et al., 2001). Importantly, a nuclear export signal (NES) in IκB-α precludes high steady-state levels of these complexes in the nucleus (Huang et al., 2000). By contrast, NF-κB–IκBβ complexes fail to undergo such shuttling because IκBβ can mask both NLSs (Malek et al., 2001). This depends on its association with the Ras-like protein, κB-Ras (Chen et al., 2003). κB-Ras also increases the stability of IκBβ (Kanayama et al., 2004).NF-κB complexes containing the precursor proteins p105 and p100 self-inactivate (Ghosh et al., 1998). Interestingly, other IκB members can form part of active transcriptional complexes at specific promoters. Thus NF-κB-inducible IκBζ (also known as MAIL and INAP) interacts with p50 and promotes transcription at the IL-6 promoter (Yamamoto et al., 2004). A highly related protein, Bcl-3, interacts with p50 and p52 dimers and forms active transcriptional complexes (Bours et al., 1993; Dechend et al., 1999). However, some studies show it represses transcription (Richard et al., 1999; Wessells et al., 2004).Activation of NF-κB classically depends on degradation of IκB. A pre-requisite is prior phosphorylation of IκB on two key N-terminal serines by IκB kinases (IKKs) (Yamamoto and Gaynor, 2004). IKK activity resides in a large protein complex comprising two catalytic subunits, IKKα and IKKβ, and a scaffolding subunit, IKKγ/NEMO. The phosphorylation of IκB proteins is followed by the binding of the E3IκB ubiquitin ligase complex β-TrCP-SCF, which polyubiquitinylates IκB and targets it for degradation by the 26S proteasome (Karin and Ben-Neriah, 2000). Activators of the IKK complex include mitogen-activated protein kinase kinase kinases (MAP3Ks) such as MEKK1, MEKK3 and TAK1 and it represents a convergence point for numerous stimuli, including ligands for Toll-like receptors (TLRs), IL-1/IL-18 receptors, the TNF receptor superfamily, and B and T cell receptors.TLRs detect pathogen-associated molecules and induce pro-inflammatory proteins and co-stimulatory molecules that trigger innate and adaptive immunity (O'Neill, 2004). TLRs employ many of the same signalling components as the IL-1 and IL-18 receptors (Martin and Wesche, 2002). These receptors share a conserved Toll/IL-1R (TIR) domain and form dimeric receptor complexes with the same or different TIR-domain-containing proteins. These complexes also recruit intracellular TIR-domain-containing adapter proteins. Four such adapter proteins have been well characterised: Myd88, Mal/TIRAP, TRIF/TICAM-1 and TRAM/TICAM-2 (O'Neill et al., 2003). With the exception of TLR3, Myd88 is universally recruited to all the above receptor complexes (Janssens and Beyaert, 2002). The use of the other adapters is more restricted to specific TLR members. These adapters recruit and activate members of the IRAK family (Martin and Wesche, 2002). IRAK-1 is initially
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
TAK1 is a ubiquitin-dependent kinase of MKK and IKK
Wang, C., Deng, L., Hong, M., Akkaraju, G. R., Inoue, J.-I., & Chen, Z. J. (2001) · Nature · doi:10.1038/35085597 · Cited by 2,125
Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaughter, C., Pickart, C., & Chen, Z. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00126-4 · Cited by 1,872
Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
Yamamoto, Y., & Gaynor, R. B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11914 · Cited by 1,585
Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway
Senftleben, U., Cao, Y., Xiao, G., Greten, F. R., Krähn, G., Bonizzi, G., Chen, Y., Hu, Y., Fong, A., Sun, S.-C., et al. (2001) · Science · doi:10.1126/science.1062677 · Cited by 1,359
Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J.-I., Cao, Z., & Matsumoto, K. (1999) · Nature · doi:10.1038/18465 · Cited by 1,182
The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination
Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israël, A., Wallach, D., & Courtois, G. (2003) · Nature · doi:10.1038/nature01802 · Cited by 1,016
CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members
Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A., & Mosialos, G. (2003) · Nature · doi:10.1038/nature01803 · Cited by 961
Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB
Brummelkamp, T. R., Nijman, S. M. B., Dirac, A. M. G., & Bernards, R. (2003) · Nature · doi:10.1038/nature01811 · Cited by 952
TAB2 and TAB3 Activate the NF-κB Pathway through Binding to Polyubiquitin Chains
Kanayama, A., Seth, R. B., Sun, L., Ea, C.-K., Hong, M., Shaito, A., Chiu, Y.-H., Deng, L., & Chen, Z. J. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.008 · Cited by 888
NF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100
Xiao, G., Harhaj, E. W., & Sun, S.-C. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00187-3 · Cited by 834
IκB kinases: key regulators of the NF-κB pathway
Yamamoto, Y., & Gaynor, R. B. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.12.003 · Cited by 640
Functions of NF-κB1 and NF-κB2 in immune cell biology
BEINKE, S., & LEY, S. C. (2004) · Biochemical Journal · doi:10.1042/bj20040544 · Cited by 610
Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression
Yamamoto, Y., Verma, U. N., Prajapati, S., Kwak, Y.-T., & Gaynor, R. B. (2003) · Nature · doi:10.1038/nature01576 · Cited by 577
Regulation of proliferation, survival and apoptosis by members of the TNF superfamily
Gaur, U., & Aggarwal, B. B. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00490-8 · Cited by 558
A nucleosomal function for IκB kinase-α in NF-κB-dependent gene expression
Anest, V., Hanson, J. L., Cogswell, P. C., Steinbrecher, K. A., Strahl, B. D., & Baldwin, A. S. (2003) · Nature · doi:10.1038/nature01648 · Cited by 522
The signaling adaptors and pathways activated by TNF superfamily
Dempsey, P. W., Doyle, S. E., He, J. Q., & Cheng, G. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00021-2 · Cited by 504
Bours, V (1993) · Cell · doi:10.1016/0092-8674(93)90401-b · Cited by 495
The Toll–IL-1 receptor adaptor family grows to five members
O'Neill, L. A. J., Fitzgerald, K. A., & Bowie, A. G. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00115-7 · Cited by 491
Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζ
Yamamoto, M., Yamazaki, S., Uematsu, S., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Kuwata, H., Takeuchi, O., Takeshige, K., et al. (2004) · Nature · doi:10.1038/nature02738 · Cited by 460
The atypical PKC-interacting protein p62 channels NF-kappa B activation by the IL-1-TRAF6 pathway
Sanz, L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.7.1576 · Cited by 436
Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family
Martin, M. U., & Wesche, H. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00320-8 · Cited by 426
A universal role for MyD88 in TLR/IL-1R-mediated signaling
Janssens, S., & Beyaert, R. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02145-x · Cited by 408
The essential role of MEKK3 in TNF-induced NF-κB activation
Yang, J., Lin, Y., Guo, Z., Cheng, J., Huang, J., Deng, L., Liao, W., Chen, Z., Liu, Z.-G., & Su, B. (2001) · Nature Immunology · doi:10.1038/89769 · Cited by 396
Huang, T. T., Kudo, N., Yoshida, M., & Miyamoto, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1014 · Cited by 380
ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway
Kopp, E., Medzhitov, R., Carothers, J., Xiao, C., Douglas, I., Janeway, C. A., & Ghosh, S. (1999) · Genes & Development · doi:10.1101/gad.13.16.2059 · Cited by 334
The Bcl-3 oncoprotein acts as a bridging factor between NF-κB/Rel and nuclear co-regulators
Dechend, R., Hirano, F., Lehmann, K., Heissmeyer, V., Ansieau, S., Wulczyn, F. G., Scheidereit, C., & Leutz, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202717 · Cited by 312
Chen, L.-F., & Greene, W. C. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0469-0 · Cited by 275
The role of Toll-like receptors and Nod proteins in bacterial infection
PHILPOTT, D., & GIRARDIN, S. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.06.012 · Cited by 271
Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3
Huang, Q., Yang, J., Lin, Y., Walker, C., Cheng, J., Liu, Z.-G., & Su, B. (2004) · Nature Immunology · doi:10.1038/ni1014 · Cited by 266
PDK1 Nucleates T Cell Receptor-Induced Signaling Complex for NF-κB Activation
Lee, K.-Y., D'Acquisto, F., Hayden, M. S., Shim, J.-H., & Ghosh, S. (2005) · Science · doi:10.1126/science.1107107 · Cited by 253
NF‐κB: A Multifaceted Transcription Factor Regulated at Several Levels
Schmitz, M. L., Mattioli, I., Buss, H., & Kracht, M. (2004) · ChemBioChem · doi:10.1002/cbic.200400144 · Cited by 245
RelB Cellular Regulation and Transcriptional Activity Are Regulated by p100
Solan, N. J., Miyoshi, H., Carmona, E. M., Bren, G. D., & Paya, C. V. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109619200 · Cited by 224
BCL-3 and NF-κB p50 Attenuate Lipopolysaccharide-induced Inflammatory Responses in Macrophages
Wessells, J., Baer, M., Young, H. A., Claudio, E., Brown, K., Siebenlist, U., & Johnson, P. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404246200 · Cited by 197
Malek, S., Chen, Y., Huxford, T., & Ghosh, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105865200 · Cited by 177
Innate immunity via Toll-like receptors and Nod proteins
Athman, R. (2004) · Current Opinion in Microbiology · doi:10.1016/j.mib.2003.12.013 · Cited by 155
TLRs: Professor Mechnikov, sit on your hat
O'Neill, L. A. J. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.10.005 · Cited by 140
T-cell-receptor- and B-cell-receptor-mediated activation of NF-κB in lymphocytes
Weil, R., & Israël, A. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.03.003 · Cited by 125
NF‐ĸB activation pathways induced by T cell costimulation
Schmitz, M. L., Bacher, S., & Dienz, O. (2003) · The FASEB Journal · doi:10.1096/fj.02-1100rev · Cited by 77
Interleukin-9 Regulates NF-κB Activity Through BCL3 Gene Induction
Richard, M., Louahed, J., Demoulin, J., & Renauld, J. (1999) · Blood · doi:10.1182/blood.v93.12.4318 · Cited by 66
Chen, Y., Wu, J., & Ghosh, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301021200 · Cited by 38
Cited by
Cummins, E. P., Berra, E., Comerford, K. M., Ginouves, A., Fitzgerald, K. T., Seeballuck, F., Godson, C., Nielsen, J. E., Moynagh, P., Pouyssegur, J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602235103 · Cited by 788
Self-citationBreast cancer stem cells, cytokine networks, and the tumor microenvironment
Korkaya, H., Liu, S., & Wicha, M. S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57099 · Cited by 616
Liu, G., Friggeri, A., Yang, Y., Park, Y.-J., Tsuruta, Y., & Abraham, E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901216106 · Cited by 438
Cell-cell communication: New insights and clinical implications
Su, J., Song, Y., Zhu, Z., Huang, X., Fan, J., Qiao, J., & Mao, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01888-z · Cited by 433
Regulation of Cancer Stem Cells by Cytokine Networks: Attacking Cancer's Inflammatory Roots
Korkaya, H., Liu, S., & Wicha, M. S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2743 · Cited by 334
Metadata
- Authors
- Moynagh, P. N.
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 2005-10-15
- Volume
- 118
- Issue
- 20
- Pages
- 4589-4592
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W2164053161
- Cited by
- 489
- References
- 44
- FWCI
- 7.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.